I see whodat is back to bashing the stock. He said NAVB cant bear any more BAD NEWS.
Yesterday they announced another grant for $1.8 million for KS trials. Wow that is BAD NEWS
Q1 lymphoseek sales jumped from $2.1 million to $4.7 million. Climbing sales are BAD NEWS
They guided 2016 sales up from $10 million to $24 million, Wow that is more BAD NEWS
The new chairman said they are reaching break even. Ouch! More BAD NEWS
The company puts out 99% good news, skin tag. One bad news and you bashers start pumping each others peckers. Get a life.